Wednesday’s Highlights at Noon: Halozyme (HALO), Organovo Holdings (ONVO), Mosaic Co (MOS), MannKind (MNKD), Renesola (SOL)

So far Wednesday, February 24, NASDAQ is up 5.78% and the S&P is up 4.84%. Here are this morning’s most active stocks: Halozyme (HALOResearch Report), Organovo Holdings (ONVOResearch Report), Mosaic Co (MOSResearch Report), MannKind (MNKDResearch Report) and Renesola (SOLResearch Report).

Halozyme is up 13.94% in midday trading to $55.00. Shares opened today at $48.27. The company has a 52-week low of $12.71 and a 52-week high of $51.30. On the Street’s front, the average 12-month analyst price target for the stock is $52.33, marking a 8.41% potential upside from current levels. In a report released today, BMO analyst Do Kim maintained a Buy rating on HALO, with a price target of $66.00, which implies an upside of 37% from current levels. Separately, on December 11, Citigroup’s Joel Beatty maintained a Hold rating on the stock and has a price target of $41.00. In the last 30 days, insiders purchased $4.13M worth of HALO shares. Over the last 3 months, the insider sentiment on Halozyme has been negative based on 37 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Organovo Holdings is up 11.77% in midday trading to $13.66. Shares opened today at $12.22. The company has a 52-week low of $3.87 and a 52-week high of $23.92.

Mosaic Co is up 11.51% in midday trading to $32.95. Shares opened today at $29.55. The company has a 52-week low of $6.50 and a 52-week high of $31.05. On the Street’s front, the average 12-month analyst price target for the stock is $32.33, marking a 9.41% potential upside from current levels. In a report issued on February 22, RBC analyst Andrew Wong maintained a Buy rating on MOS, with a price target of $36.00, which represents a potential upside of 22% from where the stock is currently trading. Separately, on the same day, CIBC World Markets’ Jacob Bout maintained a Hold rating on the stock and has a price target of $30.00.

See today’s analyst top recommended stocks >>

MannKind is up 10.73% in midday trading to $6.09. Shares opened today at $5.50. The company has a 52-week low of $0.80 and a 52-week high of $6.19. On the Street’s front, the average 12-month analyst price target for the stock is $7.50, marking a 36.36% potential upside from current levels. In a report released today, BTIG analyst Robert Hazlett maintained a Buy rating on MNKD, with a price target of $8.00, which implies an upside of 45% from current levels.

See today’s analyst top recommended stocks >>

Renesola is up 8.06% in midday trading to $15.95. Shares opened today at $14.76. The company has a 52-week low of $0.85 and a 52-week high of $35.77. On the Street’s front, the average 12-month analyst price target for the stock is $12.00, marking a -18.70% potential downside from current levels. In a report issued on December 14, H.C. Wainwright analyst Amit Dayal assigned a Buy rating on SOL, with a price target of $12.00, which reflects a potential downside of -19% from last closing price. Over the last 3 months, the insider sentiment on Renesola has been negative based on 8 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.